B. Heublein

发表

Volumetric remodeling of the proximal left coronary artery: early versus late after heart transplantation.

A. Haverich, R. Meliß, K. Pethig, 1999, Journal of the American College of Cardiology.

Impact of vascular branching sites on focal progression of allograft vasculopathy in transplanted hearts.

A. Haverich, T. Kofidis, K. Pethig, 2001, Atherosclerosis.

Randomized comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries.

C. Visser, M. de Boer, K. Oldroyd, 2004, The American journal of cardiology.

Preventive treatment of coronary vasculopathy in heart transplantation by inhibition of smooth muscle cell proliferation with angiopeptin.

A. Haverich, M. Jurmann, A. Mügge, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

REstenosis STent (REST)-study: Randomized trial comparing stenting and balloon angioplasty for treatment of restenosis after balloon angioplasty

R. Erbel, M. Nobuyoshi, C. Macaya, 1996 .

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial

Raimund Erbel, Neil Weissman, Michael Haude, 2007, The Lancet.

Immediate stent implantation versus conventional techniques for the treatment of abrupt vessel closure or symptomatic dissections after coronary balloon angioplasty.

R. Erbel, W. Rutsch, U. Tebbe, 2000, American heart journal.

Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors

K. Theisen, H. Mudra, V. Klauss, 2000, Heart.

Mechanism of luminal narrowing in cardiac allograft vasculopathy: inadequate vascular remodeling rather than intimal hyperplasia is the major predictor of coronary artery stenosis. Working Group on Cardiac Allograft Vasculopathy.

A. Haverich, K. Pethig, B. Heublein, 1998, American heart journal.

Usefulness of increased myocardial cyclic adenosine 3',5'-monophosphate content as a sign of rejection after cardiac transplantation.

W. Schmitz, P. Lichtlen, H. E. von der Leyen, 1995, The American journal of cardiology.

Impaired coronary dilator responses to substance P and impaired flow-dependent dilator responses in heart transplant patients with graft vasculopathy.

M. Kuhn, A. Haverich, P. Lichtlen, 1993, Journal of the American College of Cardiology.

Changes in cardiac beta 1- and beta 2-adrenoceptor densities after human cardiac transplantation: relation to transplant coronary vasculopathy and pretransplantation disease.

M. Steinfath, W. Schmitz, A. Haverich, 1992, American heart journal.

Increased myocardial cAMP in patients with transplant coronary vasculopathy

W. Schmitz, A. Haverich, P. Lichtlen, 1992, The Lancet.

Intraoperative echocardiography to detect and prevent tricuspid valve regurgitation after heart transplantation.

H. Schäfers, A. Haverich, B. Heublein, 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Imaging of Pulmonary Artery and Vein Anastomoses by Transesophageal Echocardiography After Lung Transplantation

W. Daniel, A. Haverich, D. Hausmann, 1992, Circulation.

Vascular remodeling in cardiac allograft vasculopathy

A. Haverich, K. Pethig, B. Heublein, 2000, Zeitschrift für Kardiologie.

Systemic Inflammatory Response in Cardiac Allograft Vasculopathy: High-Sensitive C-Reactive Protein Is Associated With Progressive Luminal Obstruction

A. Haverich, K. Pethig, B. Heublein, 2000, Circulation.

Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia.

A. Haverich, K. Pethig, B. Heublein, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Decrease in β1- and increase in β2-adrenoceptors in long-term follow-up after orthotopic cardiac transplantation

M. Steinfath, W. Schmitz, A. Haverich, 1992 .

Pulsed steroids for treatment of cardiac rejection after transplantation. What dosage is necessary?

A. Haverich, B. Heublein, T. Wahlers, 1989, Circulation.

Transesophageal Echocardiography in Candidates for Percutaneous Balloon Mitral Valvuloplasty

W. Daniel, P. Lichtlen, A. Mügge, 1994 .

Diastolic dysfunction during acute cardiac allograft rejection.

R. Hetzer, W. Daniel, A. Haverich, 1990, Circulation.

Steal phenomenon caused by a parallel branch of the internal mammary artery.

C. Schmid, B. Heublein, H. Borst, 1990, The Annals of thoracic surgery.

Hyperacute rejection in heart allografts. Case studies.

A. Haverich, G. Ziemer, A. Georgii, 1991, Pathology, research and practice.

Impact of chronic infection with chlamydia pneumoniae on incidence of cardiac allograft vasculopathy.

A. Haverich, K. Pethig, B. Heublein, 2000, Transplantation.

Detection and quantification of left main coronary artery stenosis by two-dimensional echocardiography.

P. Romaniuk, B. Heublein, N. Kanemoto, 1983, Japanese heart journal.

Nisoldipine versus isosorbide dinitrate in coronary heart disease: results of a double-masked study.

I. Amende, B. Heublein, H. Breuer, 1996, Clinical therapeutics.

Cardiac allograft vasculopathy – coronary interventions and surgical options

A. Haverich, K. Pethig, B. Heublein, 2000, Zeitschrift für Kardiologie.

Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol.

D. Modersohn, B. Heublein, N. Franz, 1991, European heart journal.

Coating of cardiovascular stents with a semiconductor to improve their hemocompatibility.

A. Bolz, M. Schaldach, B. Heublein, 1996, Texas Heart Institute journal.

Current experience with somatostatin analogues, especially angiopeptine, for the prevention of transplant vasculopathy in heart transplantation.

K. Pethig, B. Heublein, T. Wahlers, 1998, Transplantation proceedings.

What Dosage Is Necessary?

A. Haverich, B. Heublein, T. Wahlers, 2005 .

Silicon carbide-coated stents

B. Heublein, 2005 .

Preliminary Results after Application of Absorbable Metal Stents in Patients with Critical Limb Ischemia

Bernd Heublein, Marc Bosiers, Patrick Peeters, 2005, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Comparison of Enoximone and Piroximone in Patients After Mitral Valve Operation: A Prospective and Controlled Clinical Study

A. Haverich, H. E. von der Leyen, B. Heublein, 1992, Journal of cardiovascular pharmacology.

Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries

Karl-Heinz Waldmann, Axel Haverich, Claus Harder, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Left main coronary artery fistula exiting into the right atrium

A Haverich, A. Haverich, V. Kaese, 2003, Heart.

Biodegradable Drug Depots on Coronary Stents - Local Drug Delivery in Interventional Cardiology

K. Sternberg, Friedrich-Alexander-University Erlangen-Nuremberg, S. Hartwig, 2003 .

Polymerized Degradable Hyaluronan – a Platform for Stent Coating with Inherent Inhibitory Effects on Neointimal Formation in a Porcine Coronary Model

A. Haverich, R. Meliß, B. Heublein, 2002 .

ST-segment depression after cardiac transplantation and its usefulness as an indicator of acute rejection.

A. Haverich, B. Heublein, T. Wahlers, 1991, The American journal of cardiology.

Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis After Initial Balloon Angioplasty

Raimund Erbel, Michael Haude, Peter de Jaegere, 1999 .

Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.

P Serruys, R Erbel, M Haude, 1998, The New England journal of medicine.

Silicon carbide-coated stents: clinical experience in coronary lesions with increased thrombotic risk.

K. Pethig, B. Heublein, C. Özbek, 1998 .

ACE-gene polymorphism is associated with the development of allograft vascular disease in heart transplant recipients.

J. Borlak, A. Haverich, K. Pethig, 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Retrograde coronary venous contrast echocardiography: assessment of shunting and delineation of regional myocardium in the normal and ischemic canine heart.

G. Maurer, M. Torres, E. Corday, 1984, Journal of the American College of Cardiology.

Systemic recombinant tissue plasminogen activator lysis for left atrial thrombus formation after single-lung retransplantation.

A. Haverich, C. Schmid, B. Heublein, 1992, Annals of Thoracic Surgery.

Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation.

A. Herrmann, J. Schrader, H. E. von der Leyen, 2003, Human gene therapy.

Total Arterial Revascularization of the Heart using both Mammary Arteries and the Right Gastroepiploic Artery

F. Siclari, B. Heublein, D. Schaps, 1990, Journal of cardiac surgery.

Prediction of the onset of atrial fibrillation after cardiac surgery using the monophasic action potential

M. Schaldach, A. Haverich, B. Heublein, 1998, Heart.

The inferior epigastric artery for coronary bypass grafting. Functional assessment and clinical results.

H. Trappe, A. Haverich, A. Mügge, 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Multidrug resistance in heart transplant patients: a preliminary communication on a possible mechanism of therapy-resistant rejection.

A. Haverich, W. Stangel, A. Georgii, 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Cardiac allograft vasculopathy: adventitial immunoreactivity for PDGF-B and PDGFr-beta in extra- versus intramural coronary arteries.

M. Karck, A. Haverich, R. Meliß, 2001, Transplantation proceedings.

Platelet-derived growth factor rather than basic fibroblast growth factor and vascular endothelial cell growth factor is involved in adventitial narrowing causing vascular stenosis in end-stage cardiac allograft vasculopathy.

A. Haverich, Prof. Dr. med. Gustav Steinhoff, R. Meliß, 1999, Transplantation proceedings.

Impact of plaque burden on compensatory enlargement of coronary arteries in cardiac allograft vasculopathy. Working Group on Cardiac Allograft Vasculopathy.

K. Pethig, B. Heublein, T. Wahlers, 1997, The American journal of cardiology.

Safety and efficacy of bioabsorbable magnesium-alloy stent in porcine coronary arteries: morphometric analysis of a long-term study

K. Waldmann, R. Pakala, A. Haverich, 2006 .

Coronary artery stenting in cardiac allograft vascular disease.

A. Haverich, K. Pethig, B. Heublein, 1997, American heart journal.

[Unilateral lung transplantation--a new perspective in the treatment of pulmonary fibrosis].

H. Schäfers, A. Haverich, T. Wagner, 1990, Pneumologie.

Long-term Follow-up after Orthotopic Heart Transplantation

A. Haverich, B. Heublein, H. Borst, 1990, The thoracic and cardiovascular surgeon.

Polymerized degradable hyaluronan--a platform for stent coating with inherent inhibitory effects on neointimal formation in a porcine coronary model.

A. Haverich, R. Meliß, B. Heublein, 2002, International Journal of Artificial Organs.

Treatment of rejection after heart transplantation: what dosage of pulsed steroids is necessary?

H. Schäfers, A. Haverich, J. Cremer, 1990, The Journal of heart transplantation.

Silicon Carbide-Coated Stents: Clinical Experience in Coronary Lesions with Increased Thrombotic Risk

K. Pethig, B. Heublein, C. Özbek, 1998, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

Systemic Recombinant Tissue Plasminogen Activator Lvsis for Left Atrial Thrombus Formation

A. Haverich, B. Heublein, D. Gulba, 1992 .

[Coronary vasculopathy after heart transplantation--effect of temporal onset, severity and progression on long-term prognosis].

A. Haverich, K. Pethig, B. Heublein, 1999, Zeitschrift fur Kardiologie.

Cardiac allograft vascular disease after orthotopic heart transplantation: methylenetetrahydrofolate reductase gene polymorphism C677T does not account for rapidly progressive forms.

G. Gross, A. Haverich, K. Pethig, 2000, Transplantation.